Holdings
Franklin Biotechnology Discovery Fund
As of Jul 31, 2026, Franklin Biotechnology Discovery Fund reported 94 positions worth US$1.07B. Largest: Jazz Pharmaceuticals Plc, Amgen Inc. and Gilead Sciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Jazz Pharmaceuticals Plc | 258K | US$65.3M | −24,702 | Jul 31, 2026 |
| Amgen Inc. | 132K | US$50.7M | −10,420 | Jul 31, 2026 |
| Gilead Sciences, Inc. | 342K | US$44.5M | −27,182 | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. | 57,013 | US$43.5M | −4,006 | Jul 31, 2026 |
| Argenx Se | 48,962 | US$41.8M | no change | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated | 85,620 | US$40.8M | −11,816 | Jul 31, 2026 |
| Revolution Medicines, Inc. | 185K | US$34.8M | −17,002 | Jul 31, 2026 |
| Guardant Health, Inc. | 197K | US$31.8M | −52,465 | Jul 31, 2026 |
| Ascendis Pharma A/s | 121K | US$29.6M | −8,824 | Jul 31, 2026 |
| Oruka Therapeutics, Inc. | 296K | US$28.6M | −20,164 | Jul 31, 2026 |